Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells.

Du J, Paz K, Thangavelu G, Schneidawind D, Baker J, Flynn R, Duramad O, Feser C, Panoskaltsis-Mortari A, Negrin RS, Blazar BR.

Blood. 2017 Jun 8;129(23):3121-3125. doi: 10.1182/blood-2016-11-752444. Epub 2017 Apr 17.

PMID:
28416503
2.

Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells.

Chen YB, Efebera YA, Johnston L, Ball ED, Avigan D, Lekakis LJ, Bachier CR, Martin P, Duramad O, Ishii Y, Han S, Jung YJ, Lee D, Kunkel L, Negrin RS, Bui JD.

Biol Blood Marrow Transplant. 2017 Apr;23(4):625-634. doi: 10.1016/j.bbmt.2017.01.069. Epub 2017 Jan 16.

3.

Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.

Duramad O, Laysang A, Li J, Ishii Y, Namikawa R.

Biol Blood Marrow Transplant. 2011 Aug;17(8):1154-68. doi: 10.1016/j.bbmt.2010.11.022. Epub 2010 Dec 8.

4.

Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells.

Wei J, Duramad O, Perng OA, Reiner SL, Liu YJ, Qin FX.

Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18169-74. Epub 2007 Oct 31.

5.

The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens.

Hsu YM, Zhang Y, You Y, Wang D, Li H, Duramad O, Qin XF, Dong C, Lin X.

Nat Immunol. 2007 Feb;8(2):198-205. Epub 2006 Dec 24.

PMID:
17187069
6.
7.

OX40 ligand shuts down IL-10-producing regulatory T cells.

Ito T, Wang YH, Duramad O, Hanabuchi S, Perng OA, Gilliet M, Qin FX, Liu YJ.

Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13138-43. Epub 2006 Aug 21.

8.

Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells.

Ito T, Kanzler H, Duramad O, Cao W, Liu YJ.

Blood. 2006 Mar 15;107(6):2423-31. Epub 2005 Nov 17.

9.

TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.

Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N, Qin FX, Yao Z, Cao W, Liu YJ.

J Exp Med. 2005 Nov 7;202(9):1213-23.

10.

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.

Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL.

J Exp Med. 2005 Oct 17;202(8):1131-9.

11.

Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation.

Duramad O, Fearon KL, Chang B, Chan JH, Gregorio J, Coffman RL, Barrat FJ.

J Immunol. 2005 May 1;174(9):5193-200.

12.

IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences.

Duramad O, Fearon KL, Chan JH, Kanzler H, Marshall JD, Coffman RL, Barrat FJ.

Blood. 2003 Dec 15;102(13):4487-92. Epub 2003 Aug 28.

13.

The TNF receptor family member CD30 is not essential for negative selection.

DeYoung AL, Duramad O, Winoto A.

J Immunol. 2000 Dec 1;165(11):6170-3.

14.

ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain.

Kasler HG, Victoria J, Duramad O, Winoto A.

Mol Cell Biol. 2000 Nov;20(22):8382-9.

Supplemental Content

Loading ...
Support Center